THE CHALLENGE
Early clinical development requires experienced medical judgment as promising antibody candidates move from preclinical development into human studies. First-in-Human and early-phase trials introduce complex decisions around patient safety, eligibility, dose escalation, emerging clinical data, and protocol execution.
​
For emerging biotech sponsors, maintaining the right level of physician oversight can be challenging without dedicated internal medical monitoring capabilities. Gaps in medical leadership can slow safety decisions, complicate investigator and site support, and create unnecessary risk as programs progress through critical early clinical milestones.
THE SOLUTION
SciLnq provides experienced physician medical monitors who integrate directly with sponsor teams to provide hands-on medical oversight throughout clinical development.
​
Our medical monitors support protocol development and interpretation, eligibility and screening decisions, investigator and site engagement, ongoing safety review, medical data review, dose-escalation activities, and the assessment of emerging clinical findings. Working alongside Clinical Operations, Pharmacovigilance, Data Management, Biostatistics, and external CRO partners, they help sponsors maintain informed medical oversight across the study.
​
For antibody programs entering First-in-Human and early-stage clinical development, our physicians bring the clinical judgment and drug development experience needed to evaluate emerging information, support timely decisions, and maintain patient safety while keeping studies moving forward.
CORE AREAS OF SUPPORT
Sponsor-Side Medical Monitoring Leadership
Provide experienced physician oversight throughout clinical development, working directly with sponsor teams to support medical decision-making, study execution, patient safety, and consistent clinical oversight.
​
Protocol & Study Design Support
Provide medical input into protocol development, eligibility criteria, dose-escalation strategies, safety monitoring plans, informed consent materials, and other study documents to support clinically sound trial execution.
​
Eligibility & Screening Support
Review complex eligibility and screening questions, provide timely medical guidance to investigators and study teams, and help ensure protocol criteria are interpreted and applied consistently across participating sites.
​
Ongoing Safety & Medical Data Review
Evaluate adverse events, laboratory findings, clinical trends, protocol deviations, and emerging study data to identify potential safety signals and support informed medical decisions throughout study conduct.
Dose Escalation & Safety Review Support
Support dose-escalation decisions, Safety Review Committee activities, and review of emerging safety and tolerability data to help sponsors make well-informed decisions as early-phase studies progress.
​
Investigator & Site Medical Support
Serve as a medical resource for investigators and clinical sites, addressing protocol interpretation, patient management, safety questions, and other medically complex issues that arise during study execution.
​
CRO & Vendor Medical Oversight
Provide sponsor-side oversight of CRO medical monitoring activities, helping maintain clear expectations, consistent medical decision-making, effective escalation pathways, and appropriate documentation across external partners.
​
Cross-Functional Medical Leadership
Partner closely with Clinical Operations, Pharmacovigilance, Clinical Data Management, Biostatistics, Regulatory Affairs, and external partners to ensure medical oversight remains aligned with patient safety and broader development objectives.
OUR COMMITMENT TO SPONSORS
Your Program's Success Is Our Priority.
​
SciLnq is built around a simple principle: our success is measured by the success of the sponsors and programs we support.
​
Our professionals bring experienced judgment, clear communication, and accountability to every engagement, working alongside sponsor teams with a shared commitment to the program and its objectives.
​
Whether strengthening medical oversight, navigating a critical development milestone, or preparing for what comes next, our focus remains the same: provide the expertise, execution, and partnership needed to help your program succeed.
​
.jpg)
HOW WE ENGAGE
Experienced Physician Oversight Integrated Directly With Your Clinical Team.
​
Our medical monitors bring extensive clinical and drug development experience to antibody programs entering and progressing through clinical development. We integrate directly with sponsor teams to provide the medical leadership, ongoing oversight, and hands-on support needed to navigate complex clinical and safety decisions throughout study execution.
​
Rather than operating independently from your organization, our physicians become an extension of your clinical team. Working closely with Clinical Operations, Pharmacovigilance, Clinical Data Management, Biostatistics, investigators, and CRO partners, they provide timely medical guidance, evaluate emerging clinical and safety information, and help sponsors make informed decisions while maintaining patient safety and keeping development programs moving forward.
WHY SCILNQ
Effective Medical Monitoring Requires Experienced Physician Judgment at the Moments That Matter Most.
​
SciLnq provides experienced physician medical monitors who understand the demands of early clinical development and the importance of timely, informed medical decision-making. Our physicians integrate directly with sponsor teams, bringing the clinical judgment and drug development experience needed to support investigators, evaluate emerging safety and clinical information, and provide consistent medical oversight throughout study execution.
​
For First-in-Human and early-stage antibody programs, we help sponsors maintain appropriate physician oversight while supporting patient safety, efficient study execution, and confident development decisions.
READY TO STRENGTHEN YOUR MEDICAL OVERSIGHT?
Whether you're preparing an antibody program for its first clinical trial, advancing through dose escalation, or strengthening sponsor-side medical oversight of an ongoing study, SciLnq provides experienced physician leadership that integrates directly with your team and helps keep critical clinical decisions moving forward.